Question- Cetuximab is an epidermal growth factor receptor (EGFR) monoclonal antibody used to treat head and neck and advanced colorectal cancer. What are the potential ocular toxicities associated with the use of this drug?
you could add that the mentioned drug is a suitable targeted therapy of stage IV adenocarcinoma of the lung (after performing a cytogenetic analysis showing EGFR mutation)